Marketing Reports

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.transparencymarketresearch.com/chronic-stable-angina-therapeutics-market.html

Friday, 9 May 2014

Chronic Stable Angina Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019

Transparency Market Research Reports included a detailed market survey and analysis trends on “Chronic Stable Angina Therapeutics Market”. This report also includes more info about basic overview of the industry including definitions, applications and global market industry structure. Angina is a kind of chest pain or discomfort caused by poor flow of blood in the heart. This often occurs due to narrowing of blood arteries (atherosclerosis) caused by plaque formation or blood clot.

Browse Full Report with TOC:

People with obesity, history of heart disease, diabetes, high level of blood cholesterol and smoking are high risk of getting affected with angina. Some common symptoms associated with angina include pain, pressure or strange feeling in chest, shortness of breath, lightheadedness, irregular heartbeat, nausea or vomiting and weakness. Angina may be of two types: stable angina and unstable angina. Stable angina is the most common type of angina and is characterized by predictable pattern of chest pain. On the other hand, unstable angina has no typical pattern of chest pain. Stable angina happens when the heart does not get enough oxygen to perform a work which has been asked to do such as exercise or lifting heavy weight which may also occur due to cold weather and emotional stress.

Diagnosis of chronic stable angina includes medical history examination by a doctor and few tests such as coronary angiography, coronary risk profile (special blood tests), ECG, exercise tolerance test (stress test or treadmill test), stress echocardiogram and nuclear medicine (thallium) stress test. The treatment options for chronic stable angina include lifestyle changes such as daily exercise and quitting smoking, medications, and procedures such as angioplasty and stent placement and sometimes heart bypass surgery. Most commonly used medications include nitrates, ACE inhibitors and calcium channel blockers. Nicorandil, ranolazine and ivabradine are some of the latest anti-anginal agents which are also used for treating chronic stable angina.

The global market for chronic stable angina therapeutics is expected to grow at a moderate CAGR. Some major factors driving the market growth include high prevalence of the disease, extensive research and development of new more effective molecules. According to National Institute for Health and Clinical Excellence, an estimated 2 million people suffered from with stable angina in England in 2010. American Heart Association claims that around 9.1 million people are living with stable angina in the United States. Since stable angina cannot be cured immediately, it is expected that the base population of affected people will increase over the years and such high prevalence will drive market growth particularly in developed countries. The market for chronic stable angina therapeutics is likely to face significant challenges owing to patent expiry of major drugs such as bivalirudin (Angiomax/Angiox) in 2015 in Europe and rosuvastatin (Crestor) in 2016. These patent expiries are expected to attract generic manufacturers who will intensify the competition by selling drugs at low prices.

Geographically, North America represents the largest market, followed by Europe, Asia-Pacific and Rest of the World. In Asia-Pacific, rapid urbanization leading to life style changes and emerging economy of key countries such as India and China are expected to drive the market growth. Obesity, stress and cardiovascular diseases have become very common and will drive the market in developing countries significantly. Rapidly evolving medical tourism industry will also play a key role in driving the market growth in the region as a large number of people come from foreign countries to countries like India, Indonesia, Thailand and Singapore for the treatment of chronic stable angina.

There are many pharmaceutical companies and research institutes which are engaged in the development, manufacturing and marketing of drugs for treating chronic stable angina. Some major companies and research institutes include Pfizer, Inc., Mylan, Inc., Actavis Inc., Chong Kun Dang Pharmaceutical Corp., Roxane Laboratories, Inc., Gilead Sciences, Inc., CNS, Inc., Nanjing University and King's College London.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow

More Reports On Pharmaceutical Market: -

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.transparencymarketresearch.com/radar-level-transmitters-market.html

Wednesday, 23 April 2014

Radar Level Transmitters Market - Global Industry Analysis, Trends and Forecast, 2013 - 2019

Level measurement technology is widely used across many sectors such as construction, industrial, manufacturing, oil and gas, among others. Radar level measurement technology is categorized on the basis of type as non-contacting transmitter and a contacting transmitter. Radar level measurement is based on calculation of time required for completion of trip between the transducer and sensed material level. Radar level transmitters are ideally used for harsh environment where dust, vapor, or a foaming surface prevents the usage of ultrasonic measurement.

Browse Full Report with TOC:

The radar level transmitters are used for liquids, solids, or interface application. Based on the type of radar, further classification can be done as FM-CW radar, guided wave, CW radar, and pulse radar depending on the respective applications. Radar level measurement technology relies on “echo” signal which is reflected back from the surface. Thus, radar level transmitters provide accurate and reliable results for any liquids and solids under high pressures and temperatures.

Radar level transmitters can be used for enhanced signaling capabilities, measurement validity, tank status (fill or empty), signal integrity capabilities and process change (appearance of foam) across the measurement range.Moreover, issues related to environmental regulations and safety are the factors which will drive the demand of radar leveltransmitters. The use of this technology for difficult applications such as unusual tank shapes, electromagnetic interference, and high process temperatures are restricting the growth of the market. Developments such as tank graphs can be focused by the companies for further advancements in the radar level measurement market.

Some of the key players in the market include Emerson, Siemens, ABB, and Magnetrol among the others. The companies are focused on factors such as simple installation, operation, reduced money and time for the products and applications they offer in the radar level transmitter market.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

More Reports on Semiconductor and Electronics Market:

http://www.transparencymarketresearch.com/semiconductor-market-reports-5.html

About Us:-

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

Antifungal Drugs Market: Technologies, Size and Global Industry Analysis

Fungal infections occur due to unhygienic, damp, and unclean environment. They are caused by microscopic organisms that can invade the epithelial tissue. Most dermal infections are the tinea group of infections and are commonly observed in people. They affect nails, hair, scalp, and the skin in various areas of the body. Systemic fungal infections are caused by the ingestion or inhalation of spores and cause fungal pneumonia and opportunistic fungus causes diseases such as candidaisis, meningitis, mucormycosis and some others. There is a very broad base of fungal diseases in humans and infections are a common occurrence. Although most infections are non-lethal, they are very uncomfortable to live with and also create stigma or uneasiness for the patients and the people around them.

Browse Full Report with TOC: http://www.transparencymarketresearch.com/antifungal-drugs.html

Antifungal drugs act in various mechanisms such as in inhibition of cell wall formation, cell membrane disruption, and in inhibition of cell division. The market for antifungal therapies includes different applications such as drugs, powders, ointments, and pastes. Major market drivers include increasing unhygienic conditions in developed cities and countries around the world, increasing population coming in contact with resistant fungal strains and infections. The market is highly competitive at both global and local levels. The restraints for the market are the increasing resistance of fungi, use of traditional medicines to control fungus, and allergic reaction to some types of anti-fungal drugs such as azoles which cause anaphylaxis.

The antifungal drugs market is considered to be a very popular over-the-counter drug segment particularly for dermal infections. Recent advances in technology and drug delivery has presented targeted therapy to be a vital part of antifungal drugs. Large numbers of physicians are gaining advantages from other technological advancements such as diagnostic tests and devices to extract and treat the correct strain of infection.

Conventional broad spectrum anti-biotics are not the choice of use now and it is predicted that the market will continue moving in the current focused trend in the coming years. Invasive aspergillosis is the new attention of most pharmaceutical companies and the leading cause of death in transplant operations in people. Generic competition of the drugs is very strong in the antifungal segment and is predicted to earn around 65% - 70% of total market revenues.

This research report analyzes this market depending on its market segments, major geographies, and current market trends.

Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

More Reports on Pharmaceutical Market: http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Website: http://www.transparencymarketresearch.com/

Browse Market Research Report:-

http://www.transparencymarketresearch.com/drug-discovery-outsourcing.html

Wednesday, 12 March 2014

Drug Discovery Outsourcing Market - Global Industry Analysis, Latest News, Market Segment And Forecast, 2013 - 2019

Drug discovery is a process of inventing a new medication in the field of pharmaceuticals, biotechnology and pharmacology. Drug discovery is a complex, lengthycomplicated and expensive process. This process is carried out in four stages namely, target identification, target validation, high-speed screening and lead optimization. Though advanced technologies are available, success rate of drug discovery is very low and the time involved is relatively high.

The final stage of drug discovery involves obtaining a patent and running clinical trials. Most of the drugs entering into clinical trials fail and obsolete from the trials thus leading to waste of time, cost and efforts. Generally, small pharmaceutical companies develop new drug molecules and sell patent rights to big companies that can afford to conduct clinical trials. In order to focus on core competencies such as manufacturing, marketing and product labeling many companies outsource their drug discovery processes.

Browse Full Report with TOC:

Outsourcing of drug discovery saves time, cost and efforts of the pharmaceutical and biological companies. On the other hand companies providing outsourced services for drug discovery are equipped with developed infrastructure, highly developed technological front and skilled expertise. Rapidly progressing technologies, reduced turn-around time, increasing strategic partnerships and development of biosimilars, biologics and orphan drugs are some of the driving forces for the growth of the global drug discovery outsourcing market.Though the market scope for drug discovery outsourcing market is vast, increase in clinical research organizations (CROs), regional expansion, niche CROs and public-private partnerships is leading to increased competition that is restraining growth of this market.

The market of drug discovery outsourcing is segmented depending on various types of services offered such as:

Biological services
Chemical services
Lead Identification and screening
Lead optimization

Geographically, the global drug discovery outsourcing market can be categorized into North America, Europe, Asia-Pacific and rest of the world regions.North America currently leads this market and is followed by Europe due to existence and early adoption of highly developed technologies and supportive economy.

Especially countries like China and India are promising regions, reason being many small biopharmaceutical companies prefer outsourcing their drug discovery activities to CROs in China and India. Some of the market players in this industry segment are Galapagos NV, WIL Research Laboratories LLC, Albany Molecular Research, Inc. and Domainex, Ltd.

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include

North America
Asia Pacific
Europe
Rest of the World

This report provides comprehensive analysis of

Market growth drivers
Factors limiting market growth
Current market trends
Market structure
Market projections for upcoming years

Reasons for Buying this Report

This report provides pin-point analysis for changing competitive dynamics
It provides a forward looking perspective on different factors driving or restraining market growth
It provides a technological growth map over time to understand the industry growth rate
It provides a seven-year forecast assessed on the basis of how the market is predicted to grow
It helps in understanding the key product segments and their future

More Reports On Pharmaceutical Market: -

http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

About Us:-

TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources along with various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information which is indispensable for businesses to sustain their competitive edge.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us

Sheela AK

State Tower,

90 State Street,

Suite 700,

Albany NY – 12207

United States

Tel: +1-518-618-1030

Website: http://www.transparencymarketresearch.com/

Browse Market Researche Report:-